RhumbLine Advisers
PRVA icon

RhumbLine Advisers’s Privia Health PRVA Stock Holding History

RhumbLine Advisers’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.32M Sell
284,515
-16,426
-5% -$381K 0.01% 1268
2026
Q1 		$6.19M Sell
300,941
-7,940
-3% -$179K 0.01% 1293
2025
Q4 		$7.32M Sell
308,881
-19,589
-6% -$477K 0.01% 1206
2025
Q3 		$8.18M Buy
328,470
+9,310
+3% +$200K 0.01% 1177
2025
Q2 		$7.34M Buy
319,160
+24,807
+8% +$574K 0.01% 1207
2025
Q1 		$6.61M Buy
294,353
+7,153
+2% +$166K 0.01% 1218
2024
Q4 		$5.61M Buy
287,200
+3,658
+1% +$72.5K 0.01% 1368
2024
Q3 		$5.16M Sell
283,542
-12,304
-4% -$235K ﹤0.01% 1409
2024
Q2 		$5.14M Sell
295,846
-5,394
-2% -$95.6K ﹤0.01% 1383
2024
Q1 		$5.9M Buy
301,240
+3,659
+1% +$77.3K 0.01% 1322
2023
Q4 		$6.85M Buy
297,581
+8,919
+3% +$200K 0.01% 1241
2023
Q3 		$6.64M Buy
288,662
+57,669
+25% +$1.47M 0.01% 1198
2023
Q2 		$6.03M Buy
230,993
+167,004
+261% +$4.41M 0.01% 1271
2023
Q1 		$1.77M Buy
63,989
+4,704
+8% +$124K ﹤0.01% 1871
2022
Q4 		$1.35M Buy
59,285
+2,797
+5% +$77.9K ﹤0.01% 1993
2022
Q3 		$1.92M Buy
56,488
+6,143
+12% +$227K ﹤0.01% 1786
2022
Q2 		$1.47M Buy
50,345
+13,472
+37% +$343K ﹤0.01% 1936
2022
Q1 		$986K Buy
36,873
+20,464
+125% +$483K ﹤0.01% 2137
2021
Q4 		$425K Sell
16,409
-724
-4% -$18K ﹤0.01% 2577
2021
Q3 		$404K Buy
17,133
+940
+6% +$32.8K ﹤0.01% 2640
2021
Q2 		$718K Buy
+16,193
New +$597K ﹤0.01% 2395

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

RhumbLine Advisers's PRVA Position: Q2 2026 in Review

RhumbLine Advisers reduced its Privia Health (PRVA) stake by 5.5% in Q2 2026, selling an estimated $381K and leaving 284,515 shares worth $7.32M. The position accounts for 0.01% of the portfolio, ranked #1268.

RhumbLine Advisers first reported a position in PRVA in Q2 2021 and has held it in 21 quarters since. The position peaked at $8.18M in Q3 2025. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • RhumbLine Advisers held 284,515 shares of Privia Health worth $7.32M as of Q2 2026.
  • RhumbLine Advisers sold 16,426 Privia Health shares in Q2 2026, an estimated $381K.
  • Privia Health made up 0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1268 holding.
  • RhumbLine Advisers first reported a position in Privia Health in Q2 2021 and has held it in 21 quarters since.
  • RhumbLine Advisers's Privia Health position peaked at $8.18M in Q3 2025.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.